Clinical and metabolic characteristics of the study population. Table S2: Criteria for the determination of plasma lipoprotein/ lipid abnormality status. Table S3: Areas under ROC curves (AUC) and 95% confidence intervals (CI) for various anthropometric/metabolic parameters in predicting the incidence of overall dyslipidemia or different types of dyslipidemias. Results are represented as AUC (95% CI). (DOC 795 kb
Proportion of non-statin-treated patients with markers of atherogenic dyslipidemia, according to T2D...
Linear regression models for serum lipids with survey wave (DEGS1 vs. GNHIES98) as independent varia...
Anthropometric and Biochemical Characteristics of Subjects (meanâÂąâSD). Table S2. Univariate As...
Enrolment flowchart of the study population. Two hundred seventy-five participants visited the free ...
ATP III classification of total, LDL, HDL cholesterol and triglycerides (mmol/L). Table S2. Mean (95...
Baseline characteristics of the total cohort. Table S2. Comparison of AUROC for prediction of metabo...
cardiovascular disease event incidence (per 1000 person-year) of different serum lipid markers and l...
Baseline Characteristics of Respondents and Non-respondents, Tehran Lipid and Glucose Study (1999â...
Table S1. Agreement between IDF defined and the updated NCEP/ATP III defined metabolic syndrome. Num...
Table S1. ROC-Curve of all the investigated parameters in PCOS-Lean patients. Table S2. ROC-Curve of...
Table S1. Age-adjusted correlation coefficient among anthropometric indices in men and women. Table ...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Population attributable fraction and area under the receiver operating characteristic curve for obes...
Socio-demographic and clinical characteristics by diabetes status. Table S2. Adjusted means of anthr...
Figure S1. ROC-Curve of all the investigated parameters in PCOS patients. Figure S2. ROC-Curve of al...
Proportion of non-statin-treated patients with markers of atherogenic dyslipidemia, according to T2D...
Linear regression models for serum lipids with survey wave (DEGS1 vs. GNHIES98) as independent varia...
Anthropometric and Biochemical Characteristics of Subjects (meanâÂąâSD). Table S2. Univariate As...
Enrolment flowchart of the study population. Two hundred seventy-five participants visited the free ...
ATP III classification of total, LDL, HDL cholesterol and triglycerides (mmol/L). Table S2. Mean (95...
Baseline characteristics of the total cohort. Table S2. Comparison of AUROC for prediction of metabo...
cardiovascular disease event incidence (per 1000 person-year) of different serum lipid markers and l...
Baseline Characteristics of Respondents and Non-respondents, Tehran Lipid and Glucose Study (1999â...
Table S1. Agreement between IDF defined and the updated NCEP/ATP III defined metabolic syndrome. Num...
Table S1. ROC-Curve of all the investigated parameters in PCOS-Lean patients. Table S2. ROC-Curve of...
Table S1. Age-adjusted correlation coefficient among anthropometric indices in men and women. Table ...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Population attributable fraction and area under the receiver operating characteristic curve for obes...
Socio-demographic and clinical characteristics by diabetes status. Table S2. Adjusted means of anthr...
Figure S1. ROC-Curve of all the investigated parameters in PCOS patients. Figure S2. ROC-Curve of al...
Proportion of non-statin-treated patients with markers of atherogenic dyslipidemia, according to T2D...
Linear regression models for serum lipids with survey wave (DEGS1 vs. GNHIES98) as independent varia...
Anthropometric and Biochemical Characteristics of Subjects (meanâÂąâSD). Table S2. Univariate As...